REFERENCES
E. Shek. Adv. Drug Delivery Rev. 14:227–241 (1994).
M. Bebin, and T. P. Beck. Drugs 48:153–171 (1994).
G. K. E. Scriba. Arch. Pharm. 326:477–481 (1993).
G. K. E. Scriba. Pharm. Res. 10:1181–1186 (1993).
G. K. E. Scriba, D. M. Lambert, and J. H. Poupaert. J. Pharm. Pharmacol. 47:197–203 (1995).
G. K. E. Scriba, D. M. Lambert, and J. H. Poupaert. J. Pharm. Sci. 84:300–302 (1995).
R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, and E. A. Swinyard. Epilepsia 19:409–428 (1978).
S. A. Varia, S. Schuller, K. B. Sloan, and V. J. Stella. J. Pharm. Sci. 73:1068–1073 (1984).
J. J. Ashley and G. Levy. J. Pharmacokin. Biopharm. 1:99–102 (1973).
A. Vicuna, D. Lalka, P. duSouich, N. Vicuna, T. M. Ludden, and A. J. McLean. Res. Comm. Chem. Pathol. Pharmacol. 28:3–11 (1980).
E. Shek, T. Murakami, C. Nath, E. Pop, and N. S. Bodor. J. Pharm. Sci. 78:837–843 (1989).
Rights and permissions
About this article
Cite this article
Scriba, G.K.E., Lambert, D.M. Bioavailability of Phenytoin and Anticonvulsant Activity after Oral Administration of Phenytoin-bis-hydroxyisobutyrate to Rats. Pharm Res 14, 251–253 (1997). https://doi.org/10.1023/A:1012073332415
Issue Date:
DOI: https://doi.org/10.1023/A:1012073332415